Keogan M T, McDermott V G, Paulson E K, Sheafor D H, Frederick M G, de Long D M, Nelson R C
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
Radiology. 1997 Nov;205(2):513-8. doi: 10.1148/radiology.205.2.9356637.
To determine the relative value of hepatic arterial and portal venous phase helical computed tomographic (CT) scans for tumor detection and vascular opacification in patients with pancreatic malignancy.
Ninety-five patients who had or were suspected of having pancreatic disease underwent dual-phase helical CT. Arterial phase scans were acquired 20-40 seconds after contrast material administration; venous phase scans, 70-100 seconds after administration. Three readers independently scored images in a blinded fashion for the presence of tumor, for lesion attenuation relative to normal pancreas, and for vascular opacification.
The final diagnosis was pancreatic malignancy (n = 60), acute or chronic pancreatitis (n = 22), and normal pancreas (n = 13). The readers identified possible or definite tumors on arterial phase studies in 47-50 patients and on venous phase studies in 48-53 patients (P > .10). There was no statistically significant difference in tumor attenuation between scans from the two phases (P > .05). Agreement between the readers for tumor detection was not affected by the scanning phase (P > .10). Opacification of arteries and of veins was greater on arterial phase scans and on venous phase scans, respectively (P < .001).
The acquisition of arterial phase scans in addition to venous phase scans does not result in improved detection of pancreatic malignancies.
确定肝动脉期和门静脉期螺旋计算机断层扫描(CT)对胰腺恶性肿瘤患者肿瘤检测及血管显影的相对价值。
95例患有或疑似患有胰腺疾病的患者接受了双期螺旋CT检查。在注入对比剂后20 - 40秒进行动脉期扫描;注入对比剂后70 - 100秒进行静脉期扫描。三位阅片者以盲法独立对图像进行评分,评估肿瘤的存在情况、病变相对于正常胰腺的密度以及血管显影情况。
最终诊断为胰腺恶性肿瘤(n = 60)、急性或慢性胰腺炎(n = 22)以及正常胰腺(n = 13)。阅片者在动脉期研究中识别出可能或明确肿瘤的患者有47 - 50例,在静脉期研究中为48 - 53例(P > 0.10)。两个期相扫描的肿瘤密度之间无统计学显著差异(P > 0.05)。阅片者之间在肿瘤检测方面的一致性不受扫描期相的影响(P > 0.10)。动脉期扫描时动脉和静脉的显影分别比静脉期扫描时更清晰(P < 0.001)。
除静脉期扫描外增加动脉期扫描并不能提高胰腺恶性肿瘤的检测率。